About: http://webisa.webdatacommons.org/33043836

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	XTANDI and any of our potential product candidates that receive regulatory approval will face significant competition from approved drugs, drugs currently under development, and any other drugs that may subsequently be
http://www.w3.org/ns/prov#wasQuotedFrom	sec.gov